B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics. Issue 1 (23rd September 2021) - Felten, Renaud; Duret, Pierre-Marie; Bauer, Elodie; Sedmak, Nathanael; Djossou, Julien H; Bensalem, Massiva; Ardizzone, Marc; Geoffroy, Marion; Fan, Angelique; Couderc, Marion; Salmon, Jean Hugues; Messer, Laurent; et al.